| Date Filed | Type | Description |
| 10/28/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/19/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/02/2022 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 7.2% stake in Harmonic Inc. |
| 08/02/2022 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 8.3% stake in Harmonic Inc. |
| 07/14/2022 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 5.3% stake in Verra Mobility Corporation |
| 03/29/2022 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 9.6% stake in Harmonic Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2022 |
SC 13D
| SCOPIA CAPITAL MANAGEMENT LP reports a 5% stake in Verra Mobility Corporation |
| 08/05/2021 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 8.9% stake in Harmonic Inc. |
| 04/12/2021 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 9.6% stake in Harmonic Inc. |
| 03/08/2021 |
SC 13D
| SCOPIA CAPITAL MANAGEMENT LP reports a 9.6% stake in Harmonic Inc. |
| 02/16/2021 |
SC 13G
| SCOPIA CAPITAL MANAGEMENT LP reports a 9.9% stake in Harmonic Inc. |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 4.7% stake in Retrophin, Inc. |
| 01/10/2020 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 2.1% stake in Zogenix Inc. |
| 01/10/2020 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 1.4% stake in Horizon Pharma Public Limited Company |
| 01/07/2020 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 4.6% stake in Itron, Inc. |
| 11/12/2019 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 0% stake in Acorda Therapeutics, Inc. |
| 09/13/2019 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 5.6% stake in Itron, Inc. |
| 08/20/2019 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 6.1% stake in Itron, Inc. |
| 08/12/2019 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 7.9% stake in Retrophin, Inc. |
| 07/03/2019 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 7.2% stake in Itron, Inc. |
| 06/10/2019 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 9.2% stake in Itron, Inc. |
| 05/21/2019 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 10.3% stake in Itron, Inc. |
| 05/09/2019 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 10.3% stake in Itron, Inc. |
| 04/10/2019 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 1.8% stake in La Jolla Pharmaceutical Company |
| 04/03/2019 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 11.2% stake in Itron, Inc. |
| 03/13/2019 |
SC 13D/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 12.5% stake in Itron, Inc. |
| 03/11/2019 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 4.7% stake in Prothena Corporation Public Limited Company |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 4.5% stake in Spirit AeroSystems Holdings, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G
| SCOPIA CAPITAL MANAGEMENT LP reports a 9.1% stake in La Jolla Pharmaceutical Company |
| 02/14/2019 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 6.4% stake in Horizon Pharma Public Limited Company |
|